320 related articles for article (PubMed ID: 27264036)
21. Thrombophilia, clinical factors, and recurrent venous thrombotic events.
Christiansen SC; Cannegieter SC; Koster T; Vandenbroucke JP; Rosendaal FR
JAMA; 2005 May; 293(19):2352-61. PubMed ID: 15900005
[TBL] [Abstract][Full Text] [Related]
22. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation.
Francoz C; Belghiti J; Vilgrain V; Sommacale D; Paradis V; Condat B; Denninger MH; Sauvanet A; Valla D; Durand F
Gut; 2005 May; 54(5):691-7. PubMed ID: 15831918
[TBL] [Abstract][Full Text] [Related]
23. Natural history of mesenteric venous thrombosis in patients treated with vitamin K antagonists: a multi-centre, retrospective cohort study.
Dentali F; Ageno W; Witt D; Malato A; Clark N; Garcia D; McCool K; Siragusa S; Dyke S; Crowther M;
Thromb Haemost; 2009 Sep; 102(3):501-4. PubMed ID: 19718470
[TBL] [Abstract][Full Text] [Related]
24. Clinical presentations, risk factors, treatment and outcomes in patients with splanchnic vein thrombosis: a single-center experience.
Klute K; DeFilippis EM; Shillingford K; Chapin J; DeSancho MT
J Thromb Thrombolysis; 2016 Aug; 42(2):267-71. PubMed ID: 26831481
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors in noncirrhotic patients with splanchnic vein thromboses.
Amitrano L; Guardascione MA; Scaglione M; Pezzullo L; Sangiuliano N; Armellino MF; Manguso F; Margaglione M; Ames PR; Iannaccone L; Grandone E; Romano L; Balzano A
Am J Gastroenterol; 2007 Nov; 102(11):2464-70. PubMed ID: 17958760
[TBL] [Abstract][Full Text] [Related]
26. Clinical history of cancer-associated splanchnic vein thrombosis.
Valeriani E; Di Nisio M; Riva N; Caiano LM; Porreca E; Bang SM; Beyer-Westendorf J; Sartori MT; Barillari G; Santoro R; Kamphuisen PW; Alatri A; Malato A; Vidili G; Oh D; Schulman S; Ageno W;
J Thromb Haemost; 2021 Apr; 19(4):983-991. PubMed ID: 33306241
[TBL] [Abstract][Full Text] [Related]
27. Rivaroxaban or vitamin-K antagonists following early endovascular thrombus removal and stent placement for acute iliofemoral deep vein thrombosis.
Sebastian T; Hakki LO; Spirk D; Baumann FA; Périard D; Banyai M; Spescha RS; Kucher N; Engelberger RP
Thromb Res; 2018 Dec; 172():86-93. PubMed ID: 30391776
[TBL] [Abstract][Full Text] [Related]
28. Association of multiple splanchnic venous thrombosis and left renal venous thrombosis, a rare complication of pancreatitis: a case report.
Motiaa Y; Ouassou Z; Moumou H; El Otmani W
J Med Case Rep; 2019 Jun; 13(1):171. PubMed ID: 31159864
[TBL] [Abstract][Full Text] [Related]
29. Association of Splanchnic Vein Thrombosis on Survival: 15-Year Institutional Experience With 1561 Cases.
Wells PS; Theberge I; Bowdridge J; Kelly E; Kielar A; Forgie MA; John S; van Walraven C
J Am Heart Assoc; 2020 Dec; 9(24):e016600. PubMed ID: 33269616
[TBL] [Abstract][Full Text] [Related]
30. Anticoagulant therapy in patients with non-cirrhotic portal vein thrombosis: effect on new thrombotic events and gastrointestinal bleeding.
Spaander MC; Hoekstra J; Hansen BE; Van Buuren HR; Leebeek FW; Janssen HL
J Thromb Haemost; 2013 Mar; 11(3):452-9. PubMed ID: 23289370
[TBL] [Abstract][Full Text] [Related]
31. How to manage splanchnic vein thrombosis in patients with liver disease.
Riva N; Ageno W
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):281-288. PubMed ID: 38066910
[TBL] [Abstract][Full Text] [Related]
32. Splanchnic vein thrombosis predicts worse survival in patients with advanced pancreatic cancer.
Afzal A; Suhong L; Gage BF; Schoen MW; Carson K; Thomas T; Sanfilippo K
Thromb Res; 2020 Jan; 185():125-131. PubMed ID: 31812026
[TBL] [Abstract][Full Text] [Related]
33. A multicenter prospective study of risk factors and treatment of unusual site thrombosis.
Ma K; Wells P; Guzman C; Anderson D; Blostein M; Hirsch A; Lazo-Langner A; Kovacs MJ; Rodger M; Tagalakis V; Kahn SR
Thromb Res; 2016 Aug; 144():100-5. PubMed ID: 27318246
[TBL] [Abstract][Full Text] [Related]
34. Mesenteric vein thrombosis can be safely treated with anticoagulation but is associated with significant sequelae of portal hypertension.
Maldonado TS; Blumberg SN; Sheth SU; Perreault G; Sadek M; Berland T; Adelman MA; Rockman CB
J Vasc Surg Venous Lymphat Disord; 2016 Oct; 4(4):400-6. PubMed ID: 27638992
[TBL] [Abstract][Full Text] [Related]
35. Long-term risk of venous thrombosis after stopping anticoagulants for a first unprovoked event: A multi-national cohort.
Rodger MA; Scarvelis D; Kahn SR; Wells PS; Anderson DA; Chagnon I; Le Gal G; Gandara E; Solymoss S; Sabri E; Kovacs J; Kovacs MJ
Thromb Res; 2016 Jul; 143():152-8. PubMed ID: 27086275
[TBL] [Abstract][Full Text] [Related]
36. Clinical approach to splanchnic vein thrombosis: risk factors and treatment.
Riva N; Donadini MP; Dentali F; Squizzato A; Ageno W
Thromb Res; 2012 Oct; 130 Suppl 1():S1-3. PubMed ID: 23026649
[TBL] [Abstract][Full Text] [Related]
37. Anticoagulation Therapy for Portal Vein Thrombosis in Patients with Cirrhosis in a Tertiary Center Experience.
Florescu MM; Costache A; Iacob SM; Pietrareanu C; Ester C; Cerban R; Dumitru R; Grasu M; Lupescu I; Gheorghe L
J Gastrointestin Liver Dis; 2021 Sep; 30(3):374-379. PubMed ID: 34551038
[TBL] [Abstract][Full Text] [Related]
38. Survival after splanchnic vein thrombosis: A 20-year nationwide cohort study.
Søgaard KK; Darvalics B; Horváth-Puhó E; Sørensen HT
Thromb Res; 2016 May; 141():1-7. PubMed ID: 26945454
[TBL] [Abstract][Full Text] [Related]
39. Rare thromboses of cerebral, splanchnic and upper-extremity veins. A narrative review.
Martinelli I; De Stefano V
Thromb Haemost; 2010 Jun; 103(6):1136-44. PubMed ID: 20352171
[TBL] [Abstract][Full Text] [Related]
40. [The clinical manifestations and thrombotic risk factors in primary antiphospholipid syndrome].
Zhao JL; Sun YD; Zhang Y; Xu D; Wang Q; Li MT; Zeng XF
Zhonghua Nei Ke Za Zhi; 2016 May; 55(5):386-91. PubMed ID: 27143190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
